By GrabNetworks
The British Drugmaker GlaxoSmithKline said that some of its executives in China appeared to have broken the law as part of a major bribery scandal. The company also said that proposed changes to its operations would result in lower prices of its medicines in China.
Related Keywords:GSK China, Chinese law, GlaxoSmithKline, SHANGHAI, Pharmacology
Source:GrabNetworks (c). All Rights Reserved
Source: http://www.itbusinessnet.com/articles/viewarticle.jsp?id=2717525
julianne hough Sfgate Plane Crash San Francisco anderson silva Marion Bartoli Wimbledon 2013 Gena Charmaine Avery
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন